These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 32984025)
1. Comparison Between Familial Colorectal Cancer Type X and Lynch Syndrome: Molecular, Clinical, and Pathological Characteristics and Pedigrees. Xu Y; Li C; Zhang Y; Guo T; Zhu C; Xu Y; Liu F Front Oncol; 2020; 10():1603. PubMed ID: 32984025 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Molecular, Clinicopathological, and Pedigree Differences Between Lynch-Like and Lynch Syndromes. Xu Y; Huang Z; Li C; Zhu C; Zhang Y; Guo T; Liu F; Xu Y Front Genet; 2020; 11():991. PubMed ID: 32973888 [TBL] [Abstract][Full Text] [Related]
3. Familial Colorectal Cancer Type X (FCCTX) and the correlation with various genes-A systematic review. Nejadtaghi M; Jafari H; Farrokhi E; Samani KG Curr Probl Cancer; 2017; 41(6):388-397. PubMed ID: 29096939 [TBL] [Abstract][Full Text] [Related]
5. Comparison of suspected Lynch syndrome patients carrying BRCA and BRCA-like variants with Lynch syndrome probands: Phenotypic characteristics and pedigree analyses. Xu Y; Li C; Wang Z; Liu F; Xu Y Mol Genet Genomic Med; 2020 Aug; 8(8):e1359. PubMed ID: 32548945 [TBL] [Abstract][Full Text] [Related]
6. Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families. Choi YH; Lakhal-Chaieb L; Kröl A; Yu B; Buchanan D; Ahnen D; Le Marchand L; Newcomb PA; Win AK; Jenkins M; Lindor NM; Briollais L J Natl Cancer Inst; 2019 Jul; 111(7):675-683. PubMed ID: 30380125 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological differences between familial colorectal cancer type X and sporadic cancer in an isolated area of spain. Medina-Arana V; Rahy-Martín A; Delgado-Plasencia L; Martínez-Riera A; León-Ayllón D; Rodríguez-Castellano D; Bravo-Gutiérrez A; Fernández-Peralta A; González-Aguilera JJ Colorectal Dis; 2016 Nov; 18(11):O388-O396. PubMed ID: 27671100 [TBL] [Abstract][Full Text] [Related]
8. Impact of colonoscopic screening in Familial Colorectal Cancer Type X. Hatfield E; Green JS; Woods MO; Warden G; Parfrey PS Mol Genet Genomic Med; 2018 Nov; 6(6):1021-1030. PubMed ID: 30300963 [TBL] [Abstract][Full Text] [Related]
9. Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X. Sánchez-Tomé E; Rivera B; Perea J; Pita G; Rueda D; Mercadillo F; Canal A; Gonzalez-Neira A; Benitez J; Urioste M J Gastroenterol; 2015 Jun; 50(6):657-66. PubMed ID: 25381643 [TBL] [Abstract][Full Text] [Related]
10. Familial Colorectal Cancer Type X. Zetner DB; Bisgaard ML Curr Genomics; 2017 Aug; 18(4):341-359. PubMed ID: 29081690 [TBL] [Abstract][Full Text] [Related]
11. [Familial colorectal cancer type X: clinical, pathological and molecular characterization]. Ferreira S; Lage P; Sousa R; Claro I; Francisco I; Filipe B; Suspiro A; Chaves P; Rodrigues P; Albuquerque C; Nobre Leitão C Acta Med Port; 2009; 22(3):207-14. PubMed ID: 19686620 [TBL] [Abstract][Full Text] [Related]
12. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity. Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430 [TBL] [Abstract][Full Text] [Related]
13. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate. Piver MS Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of CK20, β-catenin, and MUC2/5AC/6 in Lynch syndrome and familial colorectal cancer type X. Haraldsson S; Klarskov L; Nilbert M; Bernstein I; Bonde J; Holck S BMC Clin Pathol; 2017; 17():11. PubMed ID: 28824332 [TBL] [Abstract][Full Text] [Related]
15. Adenoma and colorectal cancer risks in Lynch syndrome, Lynch-like syndrome and familial colorectal cancer type X. Bucksch K; Zachariae S; Ahadova A; Aretz S; Büttner R; Görgens H; Holinski-Feder E; Hüneburg R; Kloor M; von Knebel Doeberitz M; Ladigan-Badura S; Moeslein G; Morak M; Nattermann J; Nguyen HP; Perne C; Redler S; Schmetz A; Steinke-Lange V; Surowy H; Vangala DB; Weitz J; Loeffler M; Engel C; Int J Cancer; 2022 Jan; 150(1):56-66. PubMed ID: 34469588 [TBL] [Abstract][Full Text] [Related]
16. Cancer risks in Lynch syndrome, Lynch-like syndrome, and familial colorectal cancer type X: a prospective cohort study. Bucksch K; Zachariae S; Aretz S; Büttner R; Holinski-Feder E; Holzapfel S; Hüneburg R; Kloor M; von Knebel Doeberitz M; Morak M; Möslein G; Nattermann J; Perne C; Rahner N; Schmiegel W; Schulmann K; Steinke-Lange V; Strassburg CP; Vangala DB; Weitz J; Loeffler M; Engel C; BMC Cancer; 2020 May; 20(1):460. PubMed ID: 32448342 [TBL] [Abstract][Full Text] [Related]
17. Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome. Klarskov L; Holck S; Bernstein I; Nilbert M J Clin Pathol; 2012 Apr; 65(4):352-6. PubMed ID: 22287689 [TBL] [Abstract][Full Text] [Related]
18. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds. Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920 [TBL] [Abstract][Full Text] [Related]
19. Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer. Therkildsen C; Jönsson G; Dominguez-Valentin M; Nissen A; Rambech E; Halvarsson B; Bernstein I; Borg K; Nilbert M Eur J Cancer; 2013 Apr; 49(6):1226-35. PubMed ID: 23245329 [TBL] [Abstract][Full Text] [Related]
20. Screening of BMPR1a for pathogenic mutations in familial colorectal cancer type X families from Newfoundland. Evans DR; Green JS; Woods MO Fam Cancer; 2018 Apr; 17(2):205-208. PubMed ID: 28660566 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]